Swiss Life Holding


Solid H1 20 figures, all targets confirmed despite COVID-19

13/08/20 -"• Net profit attributable to shareholders decreased by 13% to CHF533m for H1 20 • Gross written premiums were down by 17% for H1 20 due to a special Swiss effect in 2019 but +2% on an adjusted ..."

Pages
47
Language
English
Published on
13/08/20
You may also be interested by these reports :
19/02/26
Zurich reported solid FY25 results, with double-digit increases in operating profit and net income, driven by all three businesses. In P&C, ...

17/02/26
NN Group reported strong FY25 results, with a better-than-anticipated Operating Capital Generation (OCG) of €2,089m, up 9%. The operating result also ...

17/02/26
NN Group reported solid FY25 results, with operating capital generation significantly above expectations, although partly supported by non-recurring ...

16/02/26
The Talanx (ADD ; Germany) share price has had a strong run over the past couple of years, doubling from €60 to more than €120 last summer. Over ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO